Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke

Recruiting now · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Acute Ischemic Stroke

In brief

The purpose of this study is to assess the effectiveness and safety of Qingre Huatan formula versus placebo on preventing early neurological deterioration in patients with acute ischemic stroke within 48 hours after onset.

Key facts

Study ID
NCT06857487
Run by
Dongzhimen Hospital, Beijing
People needed
72
Starts
2025-06-13
Expected to finish
2026-10-29
Last updated by the study team
2025-12-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.